Literature DB >> 7673954

Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles.

R W Orrell1, A W King, D A Hilton, M J Campbell, R J Lane, J S de Belleroche.   

Abstract

Mutations of SOD-1 have recently been associated with autosomal dominant familial amyotrophic lateral sclerosis (ALS). A patient is described with a 20 year duration of motor neuron disease, with clinical features of ALS, who was heterozygous for a point mutation ATT to ACT leading to substitution of isoleucine for threonine at codon 113 in exon 4 of SOD-1. This mutation has previously been described in two families with ALS and three apparently sporadic cases of ALS. The patient described here had a family history suggestive of autosomal dominant inheritance of this genetic mutation; other members of the family having a more typical disease duration. Unusual pathological features included neurofibrillary tangles in neurons of the globus pallidus, substantia nigra, locus coeruleus, and inferior olivary nuclei, and absence of ubiquitin immunoreactive inclusions in motor neurons. This may reflect the slow progression of the neurodegeneration associated with the SOD-1 mutation in this patient. The prolonged survival, of over 20 years, with other family members having a more typical survival of two to three years, has important implications for genetic counselling in families with ALS in addition to the fundamental biological questions concerning the influence of these mutations on disease expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673954      PMCID: PMC486027          DOI: 10.1136/jnnp.59.3.266

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

1.  Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells.

Authors:  S M de Waegh; V M Lee; S T Brady
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  Ubiquitin in motor neuron disease: study at the light and electron microscope.

Authors:  D Schiffer; L Autilio-Gambetti; A Chiò; P Gambetti; M T Giordana; F Gullotta; A Migheli; M C Vigliani
Journal:  J Neuropathol Exp Neurol       Date:  1991-07       Impact factor: 3.685

3.  Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity.

Authors:  T Siddique; D A Figlewicz; M A Pericak-Vance; J L Haines; G Rouleau; A J Jeffers; P Sapp; W Y Hung; J Bebout; D McKenna-Yasek
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

4.  Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis.

Authors:  H Mizusawa; S Matsumoto; S H Yen; A Hirano; R R Rojas-Corona; H Donnenfeld
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence.

Authors:  D C Guiroy; M Miyazaki; G Multhaup; P Fischer; R M Garruto; K Beyreuther; C L Masters; G Simms; C J Gibbs; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis.

Authors:  F Côté; J F Collard; J P Julien
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

7.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.

Authors:  S K Shankar; R Yanagihara; R M Garruto; I Grundke-Iqbal; K S Kosik; D C Gajdusek
Journal:  Ann Neurol       Date:  1989-02       Impact factor: 10.422

9.  Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases.

Authors:  V Manetto; G Perry; M Tabaton; P Mulvihill; V A Fried; H T Smith; P Gambetti; L Autilio-Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Familial progressive supranuclear palsy.

Authors:  J Brown; P Lantos; M Stratton; P Roques; M Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

View more
  17 in total

Review 1.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

Review 2.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

3.  Role of glutamate transporters in redox homeostasis of the brain.

Authors:  Stephanie M Robert; Toyin Ogunrinu-Babarinde; Kenneth T Holt; Harald Sontheimer
Journal:  Neurochem Int       Date:  2014-01-10       Impact factor: 3.921

4.  Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.

Authors:  Ralf Giess; Bettina Holtmann; Massimiliano Braga; Tiemo Grimm; Bertram Müller-Myhsok; Klaus V Toyka; Michael Sendtner
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

5.  1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis.

Authors:  Khema R Sharma; Gaurav Saigal; Andrew A Maudsley; Varan Govind
Journal:  NMR Biomed       Date:  2011-03-15       Impact factor: 4.044

6.  Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.

Authors:  Melissa M Haulcomb; Nichole A Mesnard-Hoaglin; Richard J Batka; Rena M Meadows; Whitney M Miller; Kathryn P Mcmillan; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2015-06-22       Impact factor: 3.215

7.  Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons.

Authors:  Leo F McCluskey; Felix Geser; Lauren B Elman; Vivianna M Van Deerlin; John L Robinson; Virginia M-Y Lee; John Q Trojanowski
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-05-09       Impact factor: 4.092

Review 8.  A cellular perspective on conformational disease: the role of genetic background and proteostasis networks.

Authors:  Tali Gidalevitz; Elise A Kikis; Richard I Morimoto
Journal:  Curr Opin Struct Biol       Date:  2010-01-05       Impact factor: 6.809

9.  Oxidative stress and superoxide dismutase in development, aging and gene regulation.

Authors:  R G Allen
Journal:  Age (Omaha)       Date:  1998-04

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.